NMDA receptor antagonist
Showing 1 - 25 of >10,000
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Borderline Personality Disorder Trial in Melbourne (NMDA receptor antagonist (active drug), Lactose packed capsule
Recruiting
- Borderline Personality Disorder
- NMDA receptor antagonist (active drug)
- Lactose packed capsule (inert/inactive arm)
-
Melbourne, Victoria, AustraliaMonash Alfred Psychiatry Research Centre
Sep 27, 2022
PTSD, Alzheimer, Brain Diseases Trial in Liège (Fluoroethylnormemantine (FENM))
Not yet recruiting
- PTSD
- +5 more
- Fluoroethylnormemantine (FENM)
-
Liège, BelgiumCHU of Liège - Clinical Pharmacology Unit
Jun 23, 2023
Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Nitrous Oxide, Placebo gas, MRI)
Terminated
- Depressive Disorder, Major
- Depressive Disorder, Treatment-Resistant
- Nitrous Oxide
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jul 29, 2021
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Postoperative Shivering Trial in Islamabad (Dexmedetomidine, Ketamine)
Completed
- Postoperative Shivering
-
Islamabad, Federal, PakistanPAF Hospital Islamabad
Feb 6, 2023
Depression, Alcohol Dependence Trial in West Haven (Ketalar (ketamine))
Completed
- Depression
- Alcohol Dependence
- Ketalar (ketamine)
-
West Haven, ConnecticutVA CT Healthcare Systems
Mar 5, 2020
Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)
Recruiting
- Safety Issues
- +2 more
- Proglumide
- Placebo
-
Washington, District of ColumbiaGeorgetown University
Dec 1, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
Therapy of Anti-NMDAR Encephalitis at Diagnosis
Active, not recruiting
- Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
-
Rotterdam, NetherlandsErasmus Medical Center
Sep 4, 2023
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022
Postoperative Pain Trial in Denizli (Magnesium Sulfate, normal saline isotonic solution)
Completed
- Postoperative Pain
- Magnesium Sulfate
- normal saline isotonic solution
-
Denizli, TurkeyPamukkale Univercity Medical School
May 25, 2023
Clinical-immunological Features of Anti-NMDAR Encephalitis
Active, not recruiting
- Anti NMDA Receptor Encephalitis
- Description of clinical characteristic
-
Lyon, Bron, FranceHôpital Neurologique Pierre Wertheimer / Groupement Hospitalier
Feb 12, 2023
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
MDD Trial in London (MIJ821)
Not yet recruiting
- Major Depressive Disorder
-
London, United KingdomParexel Early Phase Clinical Unit (LONDON)
Dec 18, 2022
Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,
Recruiting
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Posttraumatic
- Suvorexant
- Placebo
-
San Francisco, California
- +1 more
Nov 10, 2022
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022
Anti-NMDAR Encephalitis Trial in Paris (IA session, Rituximab)
Recruiting
- Anti-NMDAR Encephalitis
- IA session
- Rituximab
-
Paris, FranceHôpital Necker Enfants-Malades
Oct 31, 2022
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
PTSD Trial in San Francisco (CORT108297, Placebo)
Not yet recruiting
- PTSD
- CORT108297
- Placebo
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022
Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)
Not yet recruiting
- Renal Cell Carcinoma
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)
Recruiting
- COVID-19
- SARS-CoV2 Infection
- Candesartan Cilexetil
- +3 more
-
Guntur, India
- +4 more
Mar 13, 2022